The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
Joanna Schwenkgrub(Centre National de la Recherche Scientifique), Iwona Kurkowska‐Jastrzębska(Institute of Psychiatry and Neurology), Ilona Joniec‐Maciejak(Medical University of Warsaw), M Zaremba(Medical University of Warsaw), Agnieszka Cudna(Medical University of Warsaw), Dagmara Mirowska-Guzeł(Medical University of Warsaw)
Cited by 53
Related Papers
The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson's disease
|Pharmacological Reports|2014|44
Awake perception is associated with dedicated neuronal assemblies in the cerebral cortex
|Nature Neuroscience|2022|42
Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease
|Pharmacological Reports|2013|34
Deep imaging in the brainstem reveals functional heterogeneity in V2a neurons controlling locomotion
|Science Advances|2020|26
Ibudilast: a non-selective phosphodiesterase inhibitor in brain disorders
|Postępy Higieny i Medycyny Doświadczalnej|2017|23